Testing a lifestyle-and-diet program for type 2 diabetes control
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 3 study tests whether a program run by the Piemonte Association can improve blood sugar control in people with type 2 diabetes who haven’t reached their target after usual diet, exercise, and stable medicines. It also aims to check that the approach is safe for participants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to voluntarily join and sign an informed consent form.
- You have type 2 diabetes and your HbA1c (average blood sugar over about 3 months) is still above your goal despite diet, exercise, and diabetes medicines at stable doses for the past 3 months.
- You cannot have health problems or lab findings that could interfere with safety (the study doctor will review this).
- You must not currently be pregnant, planning pregnancy, or breastfeeding.
- You cannot have type 1 diabetes, alcohol abuse, or past/current illicit drug use.
- You should not have joined another clinical trial in the past year, and you must not be allergic to any ingredients used in the program/formula.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests Madalena to improve blood sugar control in adults with type 2 diabetes that hasn’t met targets despite diet, exercise, and diabetes medicines. You may join if your recent blood sugar tests and body size fall within specific ranges and you don’t have key medical exclusions.
This Phase 3 study tests whether Berlim 25/20 can improve blood sugar control and cholesterol (LDL) in adults with type 2 diabetes who haven’t met targets despite prior lifestyle guidance and treatment. It also looks at safety, including effects on the heart and medication-related side effects.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
Hear when a new Type II Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.